STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

FENNEC PHARMACEUTICALS INC.

Filed

November 20, 2025

Period of Report

November 18, 2025

Accession Number

0001012975-25-000806